Leserbrief
Circulating S100A+ myeloid subsets in PDAC: Immune phenotype before diagnostic biomarker
Clinical Immunology · 2026-08 · 286 · 110730
DOI: 10.1016/j.clim.2026.110730 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical Immunology, 2026-08. Verfasst von Zhanyun Liu. Beteiligte Einrichtung: School of Medical Technology, Tianjin University of Traditional Chinese Medicine, 10 Poyanghu Road, Jinghai Dist., Tianjin 301617, China. Electronic …. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Diagnostic specificityMyeloid subsetsPancreatic ductal adenocarcinomaS100A6S100A8
Autor:innen und Institutionen
- School of Medical Technology, Tianjin University of Traditional Chinese Medicine, 10 Poyanghu Road, Jinghai Dist., Tianjin 301617, China. Electronic address: lzycherry20041208@163.com.
Zitieren
APA
Liu, Z. (2026). Circulating S100A+ myeloid subsets in PDAC: Immune phenotype before diagnostic biomarker. Clinical Immunology, 286, 110730. https://doi.org/10.1016/j.clim.2026.110730
Vancouver
Liu Z. Circulating S100A+ myeloid subsets in PDAC: Immune phenotype before diagnostic biomarker. Clinical Immunology. 2026;286:110730. doi:10.1016/j.clim.2026.110730
BibTeX
@article{Liu2026,
author = {Liu, Zhanyun},
title = {Circulating S100A+ myeloid subsets in PDAC: Immune phenotype before diagnostic biomarker},
journal = {Clinical Immunology},
year = {2026},
volume = {286},
pages = {110730},
doi = {10.1016/j.clim.2026.110730}
}
EUVIMED